BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 19435871)

  • 21. [DZNep raises miR-200c expression to delay the invasion and migration of MGC-803 gastric carcinoma cells].
    Ning XH; Guo R; Han L; Zhang AL; Liu X; Li ZX; Kang CS; Zhang QY
    Sheng Li Xue Bao; 2015 Feb; 67(1):83-9. PubMed ID: 25672630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells.
    Burk U; Schubert J; Wellner U; Schmalhofer O; Vincan E; Spaderna S; Brabletz T
    EMBO Rep; 2008 Jun; 9(6):582-9. PubMed ID: 18483486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1.
    Gregory PA; Bert AG; Paterson EL; Barry SC; Tsykin A; Farshid G; Vadas MA; Khew-Goodall Y; Goodall GJ
    Nat Cell Biol; 2008 May; 10(5):593-601. PubMed ID: 18376396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-200c inhibits TGF-β-induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer.
    Zhou X; Men X; Zhao R; Han J; Fan Z; Wang Y; Lv Y; Zuo J; Zhao L; Sang M; Liu XD; Shan B
    Cancer Gene Ther; 2018 May; 25(3-4):68-76. PubMed ID: 29302045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-128 modulates chemosensitivity and invasion of prostate cancer cells through targeting ZEB1.
    Sun X; Li Y; Yu J; Pei H; Luo P; Zhang J
    Jpn J Clin Oncol; 2015 May; 45(5):474-82. PubMed ID: 25921099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-200c inhibits metastasis of breast cancer cells by targeting HMGB1.
    Chang BP; Wang DS; Xing JW; Yang SH; Chu Q; Yu SY
    J Huazhong Univ Sci Technolog Med Sci; 2014 Apr; 34(2):201-206. PubMed ID: 24710933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs.
    Wellner U; Schubert J; Burk UC; Schmalhofer O; Zhu F; Sonntag A; Waldvogel B; Vannier C; Darling D; zur Hausen A; Brunton VG; Morton J; Sansom O; Schüler J; Stemmler MP; Herzberger C; Hopt U; Keck T; Brabletz S; Brabletz T
    Nat Cell Biol; 2009 Dec; 11(12):1487-95. PubMed ID: 19935649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer.
    Lee JY; Park MK; Park JH; Lee HJ; Shin DH; Kang Y; Lee CH; Kong G
    Oncogene; 2014 Mar; 33(10):1325-35. PubMed ID: 23474752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-200c inhibits metastasis of breast tumor via the downregulation of Foxf2.
    Zhang T; Wan JG; Liu JB; Deng M
    Genet Mol Res; 2017 Aug; 16(3):. PubMed ID: 28829888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2.
    Park SM; Gaur AB; Lengyel E; Peter ME
    Genes Dev; 2008 Apr; 22(7):894-907. PubMed ID: 18381893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of miR-9 and miR-200c, ZEB1, ZEB2 and E-cadherin in Non-Small Cell Lung Cancers in Iran.
    Nourmohammadi B; Tafsiri E; Rahimi A; Nourmohammadi Z; Daneshvar Kakhaki A; Cho W; Karimipoor M
    Asian Pac J Cancer Prev; 2019 Jun; 20(6):1633-1639. PubMed ID: 31244281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-200c is aberrantly expressed in leiomyomas in an ethnic-dependent manner and targets ZEBs, VEGFA, TIMP2, and FBLN5.
    Chuang TD; Panda H; Luo X; Chegini N
    Endocr Relat Cancer; 2012 Aug; 19(4):541-56. PubMed ID: 22685266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epithelial-mesenchymal transition, a novel target of sulforaphane via COX-2/MMP2, 9/Snail, ZEB1 and miR-200c/ZEB1 pathways in human bladder cancer cells.
    Shan Y; Zhang L; Bao Y; Li B; He C; Gao M; Feng X; Xu W; Zhang X; Wang S
    J Nutr Biochem; 2013 Jun; 24(6):1062-9. PubMed ID: 23159064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miRNA-200c increases the sensitivity of breast cancer cells to doxorubicin through the suppression of E-cadherin-mediated PTEN/Akt signaling.
    Chen Y; Sun Y; Chen L; Xu X; Zhang X; Wang B; Min L; Liu W
    Mol Med Rep; 2013 May; 7(5):1579-84. PubMed ID: 23546450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers.
    Cochrane DR; Howe EN; Spoelstra NS; Richer JK
    J Oncol; 2010; 2010():821717. PubMed ID: 20049172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
    Qiu G; Lin Y; Zhang H; Wu D
    Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TMPRSS2-ERG gene fusions induce prostate tumorigenesis by modulating microRNA miR-200c.
    Kim J; Wu L; Zhao JC; Jin HJ; Yu J
    Oncogene; 2014 Oct; 33(44):5183-92. PubMed ID: 24186205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-200c represses migration and invasion of breast cancer cells by targeting actin-regulatory proteins FHOD1 and PPM1F.
    Jurmeister S; Baumann M; Balwierz A; Keklikoglou I; Ward A; Uhlmann S; Zhang JD; Wiemann S; Sahin Ö
    Mol Cell Biol; 2012 Feb; 32(3):633-51. PubMed ID: 22144583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-200c and HuR in ovarian cancer.
    Prislei S; Martinelli E; Mariani M; Raspaglio G; Sieber S; Ferrandina G; Shahabi S; Scambia G; Ferlini C
    BMC Cancer; 2013 Feb; 13():72. PubMed ID: 23394580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-200C and -150 play an important role in endothelial cell differentiation and vasculogenesis by targeting transcription repressor ZEB1.
    Luo Z; Wen G; Wang G; Pu X; Ye S; Xu Q; Wang W; Xiao Q
    Stem Cells; 2013 Sep; 31(9):1749-62. PubMed ID: 23765923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.